Acute ischemic stroke treatment, part 1: patient selection "the 50% barrier and the capillary index score"
Firas Al-Ali, John J Elias, Danielle E Filipkowski, James E Faber, Firas Al-Ali, John J Elias, Danielle E Filipkowski, James E Faber
Abstract
The current strategy for intra-arterial treatment (IAT) of acute ischemic stroke focuses on minimizing time from ictus to revascularization and maximizing revascularization. Employing this strategy has yet to lead to improved rates of successful outcomes. However, the collateral blood supply likely plays a significant role in maintaining viable brain tissue during ischemia. Based on our prior work, we believe that only approximately 50% of patients are genetically predisposed to have sufficient collaterals for a good outcome following treatment, a concept we call the 50% barrier. The Capillary Index Score (CIS) has been developed as a tool to identify patients with a sufficient collateral blood supply to maintain tissue viability prior to treatment. Patients with a favorable CIS (f CIS) may be able to achieve a good outcome with IAT beyond an arbitrary time window. The CIS is incorporated into a proposed patient treatment algorithm. For patients suffering from a large stroke without aphasia, a non-enhanced head CT should be followed by CT angiography (CTA). For patients without signs of stroke mimics or visible signs of structural changes due to large irreversible ischemia, CTA can help confirm the vascular occlusion and location. The CIS can be obtained from a diagnostic cerebral angiogram, with IAT offered to patients categorized as f CIS.
Keywords: acute ischemic stroke; capillary index score; intra-arterial treatment; patient selection; revascularization; stroke outcome; the 50% barrier.
Figures
References
- Nogueira R, Schwamm L, Hirsch J. Endovascular approaches to acute stroke, part 1: drugs, devices, and data. AJNR Am J Neuroradiol (2009) 30(4):649–61.10.3174/ajnr.A1486
- Kwiatkowski T, Libman R, Frankel M, Tilley B, Morgenstern L, Lu M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study group. N Engl J Med (1999) 340(23):1781–7.10.1056/NEJM199906103402302
- del Zoppo G, Higashida R, Furlan A, Pessin M, Rowley H, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke (1998) 29(1):4–11.10.1161/01.STR.29.1.4
- IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke (2004) 35(4):904–11.10.1161/01.STR.0000121641.77121.98
- IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke (2007) 38(7):2127–35.10.1161/STROKEAHA.107.483131
- Broderick J, Palesch Y, Demchuk A, Yeatts S, Khatri P, Hill M, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 368(10):893–903.10.1056/NEJMoa1214300
- Ciccone A, Valvassori L, Ponzio M, Ballabio E, Gasparotti R, Sessa M, et al. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg (2009) 2(1):74–9.10.1136/jnis.2009.001388
- Saver J, Jahan R, Levy E, Jovin T, Baxter B, Nogueira R, et al. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet (2012) 380(9849):1241–9.10.1016/S0140-6736(12)61384-1
- Nogueira R, Lutsep H, Gupta R, Jovin T, Albers G, Walker G, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 380(9849):1231–40.10.1016/S0140-6736(12)61299-9
- Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2015) 372(1):11–20.10.1056/NEJMoa1411587
- Hill MD. Endovascular treatment for small core and anterior circulation proximal occlusion with emphasis on minimizing CT to recanalization times (ESCAPE). Abstract Presented at: International Stroke Conference 2015 Nashville, TN (2015).
- Saver J, Goyal M, Bonafe A, Diener H, Levy E, Medes-Pereira V, et al. Solitaire FR with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke. Abstract Presented at: International Stroke Conference 2015 Nashville, TN (2015).
- Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. EXTEND-IA – endovascular therapy after intravenous t-PA versus t-PA alone for ischemic stroke using CT perfusion imaging selection. Abstract Presented at: International Stroke Conference 2015 Nashville, TN (2015).
- Kety S, Schmidt C. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values 1. J Clin Invest (1948) 27(4):476–8310.1172/JCI101994
- Khaja A. Acute ischemic stroke management: administration of thrombolytics, neuroprotectants, and general principles of medical management. Neurol Clin (2008) 26(4):943–61.10.1016/j.ncl.2008.07.002
- Jones T, Morawetz R, Crowell R, Marcoux F, FitzGibbon S, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 54(6):773–82.10.3171/jns.1981.54.6.0773
- Branston N, Symon L, Crockard H, Pasztor E. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol (1974) 45(2):195–20810.1016/0014-4886(74)90112-5
- Crowell R, Marcoux F, DeGirolami U. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology (1981) 31(10):1295–1295.10.1212/WNL.31.10.1295
- Olsen T. Regional cerebral blood flow after occlusion of the middle cerebral artery. Acta Neurol Scand (1986) 73(4):321–37.10.1111/j.1600-0404.1986.tb03286.x
- Al-Ali F, Tomsick T, Connors J, Gebel J, Elias J, Markarian G, et al. Capillary index score in the interventional management of stroke trials I and II. Stroke (2014) 45(7):1999–2003.10.1161/STROKEAHA.114.005304
- Menon B, Smith E, Coutts S, Welsh D, Faber J, Goyal M, et al. Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol (2013) 74(2):241–8.10.1002/ana.23906
- Lucitti J, Mackey J, Morrison J, Haigh J, Adams R, Faber J. Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17. Circ Res (2012) 111(12):1539–50.10.1161/CIRCRESAHA.112.279109
- Chalothorn D, Faber J. Formation and maturation of the native cerebral collateral circulation. J Mol Cell Cardiol (2010) 49(2):251–9.10.1016/j.yjmcc.2010.03.014
- Gielecki J, Zurada A, Kozłowska H, Nowak D, Loukas M. Morphometric and volumetric analysis of the middle cerebral artery in human fetuses. Acta Neurobiol Exp (Wars) (2009) 69(1):129–37.
- Okudera T, Ohta T, Huang Y, Yokota A. Developmental and radiological anatomy of the superficial cerebral convexity vessels in the human fetus. J Neuroradiol (1988) 15(3):205–24.
- Chalothorn D, Clayton J, Zhang H, Pomp D, Faber J. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics (2007) 30(2):179–91.10.1152/physiolgenomics.00047.2007
- Zhang H, Prabhakar P, Sealock R, Faber J. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab (2010) 30(5):923–34.10.1038/jcbfm.2010.10
- Wang S, Zhang H, Dai X, Sealock R, Faber J. Genetic architecture underlying variation in extent and remodeling of the collateral circulation. Circ Res (2010) 107(4):558–68.10.1161/CIRCRESAHA.110.224634
- Wang S, Zhang H, Wiltshire T, Sealock R, Faber J. Genetic dissection of the Canq1 locus governing variation in extent of the collateral circulation. PLoS One (2012) 7(3):e31910.10.1371/journal.pone.0031910
- Sealock R, Zhang H, Lucitti J, Moore S, Faber J. Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity. Circ Res (2013) 114(4):660–71.10.1161/CIRCRESAHA.114.302931
- Lee Y, Menon B, Huang D, Wilhelmsen K, Powers W, Jovin T, et al. GENEtic determinants of collateral status in stroke – the GENEDCSS study. Presentation Presented at; 2014; 20th International Stroke Conference (Abstract) San Diego, CA (2014).
- Faber J, Zhang H, Lassance-Soares R, Prabhakar P, Najafi A, Burnett M, et al. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol (2011) 31(8):1748–56.10.1161/ATVBAHA.111.227314
- Moore SM, Zhang H, Maeda N, Doerschuk CM, Faber JE. Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury. Angiogenesis (2015) (in press).
- Dai X, Faber J. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ Res (2010) 106(12):1870–81.10.1161/CIRCRESAHA.109.212746
- González R, Schaefer P, Buonanno F, Schwamm L, Budzik R, Rordorf G, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology (1999) 210(1):155–62.10.1148/radiology.210.1.r99ja02155
- Mullins M, Schaefer P, Sorensen A, Halpern E, Ay H, He J, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department1. Radiology (2002) 224(2):353–60.10.1148/radiol.2242010873
- Schellinger P, Bryan R, Caplan L, Detre J, Edelman R, Jaigobin C, et al. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology (2010) 75(2):177–85.10.1212/WNL.0b013e3181e7c9dd
- Jauch E, Saver J, Adams H, Bruno A, Connors J, Demaerschalk B, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke (2013) 44(3):870–94710.1161/STR.0b013e318284056a
- Sims J, Gharai L, Schaefer P, Vangel M, Rosenthal E, Lev M, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology (2009) 72(24):2104–10.10.1212/WNL.0b013e3181aa5329
- Campbell B, Purushotham A, Christensen S, Desmond P, Nagakane Y, Parsons M, et al. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 32(1):50–6.10.1038/jcbfm.2011.102
- Grant P, He J, Halpern E, Wu O, Schaefer P, Schwamm L, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain1. Radiology (2001) 221(1):43–50.10.1148/radiol.2211001523
- Lansberg M, Straka M, Kemp S, Mlynash M, Wechsler L, Jovin T, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 11(10):860–7.10.1016/S1474-4422(12)70203-X
- Šanák D, Nosál’ V, Horák D, Bártková A, Zelenák K, Herzig R, et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology (2006) 48(9):632–9.10.1007/s00234-006-0105-0
- Yoo A, Barak E, Copen W, Kamalian S, Gharai L, Pervez M, et al. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with national institutes of health stroke scale score improves the prediction of acute stroke outcome. Stroke (2010) 41(8):1728–35.10.1161/STROKEAHA.110.582874
- Yoo A, Verduzco L, Schaefer P, Hirsch J, Rabinov J, Gonzalez R. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke (2009) 40(6):2046–54.10.1161/STROKEAHA.108.541656
- Gonzalez R, Copen W, Schaefer P, Lev M, Pomerantz S, Rapalino O, et al. The Massachusetts general hospital acute stroke imaging algorithm: an experience and evidence based approach. J Neurointerv Surg (2013) 5(Suppl 1):i7–12.10.1136/neurintsurg-2013-010715
- Yoo A, Chaudhry Z, Nogueira R, Lev M, Schaefer P, Schwamm L, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke (2012) 43(5):1323–30.10.1161/STROKEAHA.111.639401
- Zaidi S, Aghaebrahim A, Urra X, Jumaa M, Jankowitz B, Hammer M, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke (2012) 43(12):3238–44.10.1161/STROKEAHA.112.671594
- Wisco D, Uchino K, Saqqur M, Gebel J, Aoki J, Alam S, et al. Addition of hyperacute MRI aids in patient selection, decreasing the use of endovascular stroke therapy. Stroke (2014) 45(2):467–72.10.1161/STROKEAHA.113.003880
- Patel S, Levine S, Tilley B, Grotta J, Lu M, Frankel M, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 286(22):2830–8.10.1001/jama.286.22.2830
- Rha J, Saver J. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 38(3):967–73.10.1161/01.STR.0000258112.14918.24
- Gonzalez R. Low signal, high noise and large uncertainty make CT perfusion unsuitable for acute ischemic stroke patient selection for endovascular therapy. J Neurointerv Surg (2012) 4(4):242–510.1136/neurintsurg-2012-010404
- Wintermark M, Albers G, Alexandrov A, Alger J, Bammer R, Baron J, et al. Acute stroke imaging research roadmap. Stroke (2008) 39(5):1621–8.10.1161/STROKEAHA.107.512319
- Dani K, Thomas R, Chappell F, Shuler K, MacLeod M, Muir K, et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol (2011) 70(3):384–401.10.1002/ana.22500
- deIpolyi A, Wu O, Macklin E, Schaefer P, Schwamm L, Gilberto Gonzalez R, et al. Reliability of cerebral blood volume maps as a substitute for diffusion-weighted imaging in acute ischemic stroke. J Magn Reson Imaging (2012) 36(5):1083–7.10.1002/jmri.23740
- Hill M, Demchuk A, Goyal M, Jovin T, Foster L, Tomsick T, et al. Alberta stroke program early computed tomography score to select patients for endovascular treatment: interventional management of stroke (IMS)-III trial. Stroke (2014) 45(2):444–9.10.1161/STROKEAHA.113.003580
- Mazighi M, Chaudhry S, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 127(19):1980–5.10.1161/CIRCULATIONAHA.112.000311
- Christoforidis G, Mohammad Y, Kehagias D, Avutu B, Slivka A. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol (2005) 26(7):1789–97.10.1161/STROKEAHA.113.004072
- Liebeskind D, Tomsick T, Foster L, Yeatts S, Carrozzella J, Demchuk A, et al. Collaterals at angiography and outcomes in the interventional management of stroke (IMS) III trial. Stroke (2014) 45(3):759–64.10.1161/STROKEAHA.113.004072
- Galimanis A, Jung S, Mono M, Fischer U, Findling O, Weck A, et al. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke (2012) 43(4):1052–7.10.1161/STROKEAHA.111.639112
- Al-Ali F, Jefferson A, Barrow T, Cree T, Louis S, Luke K, et al. The capillary index score: rethinking the acute ischemic stroke treatment algorithm. Results from the borgess medical center acute ischemic stroke registry. J Neurointerv Surg (2012) 5(2):139–4310.1136/neurintsurg-2011-010146
Source: PubMed